Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Regenerative Medicine
  4. Heat shock cognate protein 70 promotes the differentiation of C2C12 myoblast and targets Yin Yang 1

Heat shock cognate protein 70 promotes the differentiation of C2C12 myoblast and targets Yin Yang 1

Annals of Translational Medicine, 2019 · DOI: 10.21037/atm.2019.09.88 · Published: October 1, 2019

Regenerative MedicineGeneticsMusculoskeletal Medicine

Simple Explanation

This study explores the role of Heat shock cognate protein 70 (HSC70) in skeletal muscle differentiation, specifically using C2C12 myoblasts. The researchers found that HSC70 is up-regulated during myoblast differentiation and that its knockdown inhibits differentiation. Overexpression of Yin Yang 1 (YY1) can restore differentiation in cells with HSC70 knockdown. The findings suggest HSC70's critical role in myoblast differentiation via YY1, proposing it as a therapeutic target for muscle atrophy.

Study Duration
Not specified
Participants
Not specified
Evidence Level
Not specified

Key Findings

  • 1
    HSC70 expression is significantly up-regulated during C2C12 myoblast differentiation.
  • 2
    Knockdown of HSC70 inhibits C2C12 myoblast differentiation and reduces the expression of MyoD and MyoG.
  • 3
    Overexpression of Yin Yang 1 (YY1) protein promotes myoblast differentiation and restores differentiation in cells with HSC70 knockdown or inhibition.

Research Summary

This study investigates the role of HSC70 in C2C12 myoblast differentiation, finding that HSC70 is up-regulated during differentiation. The research demonstrates that HSC70 knockdown inhibits myoblast differentiation and reduces MyoD and MyoG expression, while YY1 overexpression reverses this inhibition. The study concludes that HSC70 is critical for C2C12 myoblast differentiation via YY1 and suggests it as a potential therapeutic target for muscle-related diseases.

Practical Implications

Therapeutic Target

HSC70 might become a novel therapeutic target of muscle-related disease.

Muscle Atrophy Prevention

HSC70 may serve as a potential target for a therapeutic strategy to prevent muscle atrophy.

Drug Development

HSC70 may become a potential biomarker for diagnosis and therapeutic targets for design, discovery, and development of novel drugs

Study Limitations

  • 1
    The specific mechanism of HSC70 and YY1-induced myoblast differentiation should be further explored.
  • 2
    Cooperation of co-chaperones enables HSC70 to fully perform its function.
  • 3
    This article does not involve any patients or animals, and the ethical review is exempted.

Your Feedback

Was this summary helpful?

Back to Regenerative Medicine